16:38 , Jul 20, 2018 |  BC Week In Review  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on July 17 proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. CanSino said in its prospectus that...
22:18 , Jul 17, 2018 |  BC Extra  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on Tuesday proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. The news comes as multiple media...
22:02 , Jul 17, 2018 |  BC Extra  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on Tuesday proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. The news comes as multiple media...
23:21 , Jul 13, 2018 |  BioCentury  |  Finance

Pause for politics

The near record-setting pace of 1H18 capital markets activity isn’t likely to be replicated this half, but that won’t be because of changes to sector fundamentals. Instead, it’s likely the consequence of macroeconomic and geopolitical...
03:05 , Jun 30, 2018 |  BioCentury  |  Finance

Hidden in the rough

Judicious stock picking was especially important in the second quarter, as 57% of global biotech stocks saw their equity values decline. Volatility continued to roil global markets during the period and additional uncertainty looms with the...
18:23 , Jun 29, 2018 |  BC Week In Review  |  Financial News

Innovent, MicuRx seeking Hong Kong IPOs

Immuno-oncology company Innovent Biologics Inc. (Suzhou, China) and anti-infectives company MicuRx Pharmaceuticals Inc. (Hayward, Calif.) each filed on June 28 to list on the Hong Kong stock exchange. Innovent's filing is underwritten by Morgan Stanley, Goldman...
21:16 , Jun 28, 2018 |  BC Extra  |  Financial News

Innovent, MicuRx seeking Hong Kong IPOs

Immuno-oncology company Innovent Biologics Inc. (Suzhou, China) and anti-infectives company MicuRx Pharmaceuticals Inc. (Hayward, Calif.) each filed Thursday to list on the Hong Kong stock exchange. Innovent's filing is underwritten by Morgan Stanley, Goldman Sachs, J.P....
17:57 , Jun 22, 2018 |  BC Week In Review  |  Clinical News

BMS first to cross finish line in China PD-1 approval race

The State Drug Administration approved Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY), marking China’s first approval of an immuno-oncology agent, according to the pharma. The anti-PD-1 mAb is indicated to treat locally advanced or metastatic...
21:28 , Jun 15, 2018 |  BC Extra  |  Company News

BMS scores China's first immuno-oncology approval

The State Drug Administration approved Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY), marking China’s first approval of an immuno-oncology agent, according to the pharma. The anti-PD-1 mAb is indicated to treat locally advanced or metastatic...
18:09 , Jun 1, 2018 |  BC Week In Review  |  Financial News

JHL raises $106M in bond deal

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) raised $106 million on May 15 in convertible bonds led by new investor VMS Investment Group, according to JHL CFO Ellis Chu. Also participating were new investor Ruihua...